CSIMarket
 


Biogen Inc   (BIIB)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

BIIB's Net Cash Flow Growth by Quarter and Year

Biogen Inc 's Net Cash Flow results by quarter and year




BIIB Net Cash Flow (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
IV Quarter December - -934.60 552.20 -1,166.90
III Quarter September - -184.20 640.00 1,141.90
II Quarter June - -197.60 827.10 -2,840.70
I Quarter March -80.70 -335.10 1,019.00 2,535.10
FY   -80.70 -1,651.50 3,038.30 -330.60



BIIB Net Cash Flow first quarter 2021 Y/Y Growth Comment
Biogen Inc in the first quarter recorded net cash outflow of $ -80.70 millions.

According to the results reported in the first quarter, Biogen Inc achieved the best Net Cash Flow growth in Biotechnology & Drugs industry. While Biogen Inc ' s Net Cash Flow no change of % ranks overall at the positon no. in the first quarter.




BIIB Net Cash Flow ( Y/Y Growth %) 2021
2020 2019 2018
IV Quarter December - - - -
III Quarter September - - -43.95 % 215.44 %
II Quarter June - - - -
I Quarter March - - -59.8 % -
FY   - - - -

Financial Statements
Biogen Inc 's first quarter 2021 Net Cash Flow $ -80.70 millions BIIB's Income Statement
Biogen Inc 's first quarter 2020 Net Cash Flow $ -335.10 millions Quarterly BIIB's Income Statement
New: More BIIB's historic Net Cash Flow Growth >>


BIIB Net Cash Flow (Quarter on Quarter Growth %)

2021
2020 2019 2018
IV Quarter December - - -13.72 % -
III Quarter September - - -22.62 % -
II Quarter June - - -18.83 % -
I Quarter March - - - 6128.75 %
FY (Year on Year)   - - - -




Net Cash Flow first quarter 2021 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Net Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Cash Flow first quarter 2021 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Net Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Cash Flow by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Biogen Inc 's Q/Q Net Cash Flow Growth


Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


BIIB's I. Quarter Q/Q Net Cash Flow Comment
Although Biogen Inc in the I. Quarter 2021 admitted net cash outflow of $ -80.70 millions, management mentioned, that this point to improvement relative to the -934.60 millions in the forth quarter.

Within Biotechnology & Drugs industry Biogen Inc achieved highest sequential Net Cash Flow growth. While Biogen Inc 's Net Cash Flow growth quarter on quarter, overall rank is .


Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


BIIB's I. Quarter Q/Q Net Cash Flow Comment
Even if Biogen Inc in the I. Quarter 2021 revealed net cash outflow of $ -80.70 millions, it should be point out, that current results point to slight up side in contrast to the -934.60 millions in the forth quarter.

Within Biotechnology & Drugs industry Biogen Inc achieved highest sequential Net Cash Flow growth. While Biogen Inc 's Net Cash Flow growth quarter on quarter, overall rank is .


Biogen Inc 's 12 Months Net Cash Flow Growth Year on Year


Net Cash Flow TTM Growth

12 Months Ending
(Mar 31 2021)
12 Months Ending
(Dec 31 2020)
12 Months Ending
(Sep 30 2020)
12 Months Ending
(Jun 30 2020)
12 Months Ending
(Mar 31 2020)
Cumulative Net Cash Flow 12 Months Ending $ -1,397.10 $ -1,651.50 $ -164.70 $ 659.50 $ 334.60
Y / Y Net Cash Flow Growth (TTM) - - - 39.87 % -
Year on Year Net Cash Flow Growth Overall Ranking # # # # #
Seqeuential Net Cash Flow Change (TTM) - - - 97.1 % -80.19 %
Seq. Net Cash Flow Growth (TTM) Overall Ranking # # # # #




Cumulative Net Cash Flow growth Comment
Biogen Inc realized trailing twelve months net cash outflow of $ -1,397 millions, in the Mar 31 2021, compare to Net Cash Flow of $ 335 millions a year ago.

Biogen Inc achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Net Cash Flow growth Comment
Biogen Inc realized trailing twelve months net cash outflow of $ -1,397 millions, in the Mar 31 2021, compare to Net Cash Flow of $ 335 millions a year ago.

Biogen Inc achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Net Cash Flow Growth
Biotechnology & Drugs Industry Net Cash Flow Growth Trends and Statistics
Healthcare Sector Net Cash Flow Growth Statistics
Net Cash Flow Growth Trends for overall market
BIIB's Net Cash Flow Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Growth
Lowest Ranking Net Cash Flow Growth
Net Cash Flow Growth for BIIB's Competitors
Net Cash Flow Growth for Biogen Inc 's Suppliers
Net Cash Flow Growth for BIIB's Customers

You may also want to know
BIIB's Annual Growth Rates BIIB's Profitability Ratios BIIB's Asset Turnover Ratio BIIB's Dividend Growth
BIIB's Roe BIIB's Valuation Ratios BIIB's Financial Strength Ratios BIIB's Dividend Payout Ratio
BIIB's Roa BIIB's Inventory Turnover Ratio BIIB's Growth Rates BIIB's Dividend Comparisons



Companies with similar Net Cash Flow no change for the quarter ending Mar 31 2021 within Healthcare SectorY/Y Change %Net Cash Flow for the quarter ending Mar 31 2021
Option Care Health Inc -0.89%$ -0.893 millions
Catalyst Biosciences Inc -4.20%$ -4.202 millions
Intra cellular Therapies Inc -4.67%$ -4.665 millions
Igm Biosciences Inc -7.14%$ -7.136 millions
Alector Inc -14.79%$ -14.790 millions
Myriad Genetics Inc -19.85%$ -19.849 millions
Inogen Inc -22.01%$ -22.015 millions
Verrica Pharmaceuticals Inc -26.15%$ -26.147 millions
Aclaris Therapeutics Inc -26.87%$ -26.868 millions
Biodelivery Sciences International Inc -27.85%$ -27.851 millions
Align Technology inc -28.90%$ -28.896 millions
United Therapeutics Corporation-31.58%$ -31.579 millions
Vertex Pharmaceuticals Inc-32.67%$ -32.667 millions
Syros Pharmaceuticals inc -35.91%$ -35.911 millions
Agenus Inc-35.92%$ -35.917 millions
Iradimed Corp-36.52%$ -36.522 millions
Assertio Holdings inc -36.98%$ -36.982 millions
Zymeworks Inc -37.89%$ -37.885 millions
Deciphera Pharmaceuticals Inc -39.86%$ -39.862 millions
Chiasma Inc -39.98%$ -39.980 millions
Nevro Corp -40.87%$ -40.865 millions
Xencor Inc-42.88%$ -42.880 millions
Vanda Pharmaceuticals Inc -44.17%$ -44.167 millions
Myomo Inc -44.61%$ -44.607 millions
Passage Bio Inc -44.93%$ -44.931 millions
Innoviva inc -50.73%$ -50.730 millions
Intricon Corporation-52.78%$ -52.782 millions
Enanta Pharmaceuticals Inc-52.91%$ -52.905 millions
Biomarin Pharmaceutical Inc-53.67%$ -53.670 millions
Transmedics Group Inc -53.81%$ -53.810 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

HCAT's Profile

Stock Price

HCAT's Financials

Business Description

Fundamentals

Charts & Quotes

HCAT's News

Suppliers

HCAT's Competitors

Customers & Markets

Economic Indicators

HCAT's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071